House Bill 5456, introduced today by State Representatives Laurie Sweet and Michael “MJ” Shannon, seeks to legalize the use of psilocybin for medicinal and therapeutic purposes in Connecticut.
Dried psilocybin.
The bill has been referred to the Joint Committee on Public Health for further consideration. If enacted, the proposed legislation would amend state statutes to permit the use of psilocybin in providing physical, mental, or behavioral health care. Psilocybin, the active compound found in certain species of mushrooms, has gained attention in recent years for its potential therapeutic benefits in treating conditions such as depression, anxiety, and PTSD.
The bill’s statement of purpose emphasizes the broad scope of its intent, covering various aspects of health care. This aligns with emerging research that highlights the compound’s ability to support individuals with mental health challenges when administered in controlled settings.
Representative Sweet, serving the 91st District, and Representative Shannon, representing the 117th District, have been vocal advocates for expanding access to alternative treatments. By introducing this legislation, they aim to bring Connecticut in line with a growing number of states exploring the medicinal use of psilocybin.
The measure’s next steps involve review and discussion by the Joint Committee on Public Health. If successful, House Bill 5456 could mark a significant step toward integrating psilocybin therapy into the state’s health care framework.
